16 min

Ted Slafsky on 340B, How We Got Here, and Where We're Going Redeeming Value

    • Business News

Brian talks to Ted Slafsky, the founder and principal of Wexford Solutions and publisher and CEO of 340B Report.

340B -- the program under which certain health care entities that treat underserved populations can get reduced-price prescription drugs -- has become a flashpoint this year, with six pharmaceutical companies announcing plans to restrict how they provide medications under the program. Ted joined us to talk about how the brouhaha started, why it started now, and where things go next. 

Brian talks to Ted Slafsky, the founder and principal of Wexford Solutions and publisher and CEO of 340B Report.

340B -- the program under which certain health care entities that treat underserved populations can get reduced-price prescription drugs -- has become a flashpoint this year, with six pharmaceutical companies announcing plans to restrict how they provide medications under the program. Ted joined us to talk about how the brouhaha started, why it started now, and where things go next. 

16 min

Top Podcasts In Business News